Finding Needles in the Same Haystack: Comparing Designated Medical Event vs Untargeted Approach in Signal Identification

This poster describes a project that compared signal identification using an untargeted International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) outcome with targeted screening for serious designated medical events among adults initiating semaglutide (Ozempic®) versus empagliflozin. It was presented at the 2026 ISPE Annual Meeting.